Marimed Free Cash Flow (FCF) History (MRMD)

Marimed reported $6.5M in free cash flow for fiscal 2025, an increase of $11.7M from the previous fiscal year, with a free cash flow margin of 4.08%.

View full Marimed company overview

Marimed free cash flow by year

Marimed annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31$6.5M$11.7M+4.08%
20242024-12-31−$5.2M$7.0M−3.28%
20232023-12-31−$12.2M−$7.4M−8.22%
20222022-12-31−$4.8M−$22.8M−3.60%
20212021-12-31$18.0M$19.3M+14.80%
20202020-12-31−$1.3M$32.5M−2.57%
20192019-12-31−$33.8M−$22.0M−74.13%
20182018-12-31−$11.8M$7.4M−99.83%
20172017-12-31−$19.2M−$15.6M−316.60%
20162016-12-31−$3.6M−$3.1M−99.94%
20142014-12-31−$457,890−518.07%

Marimed free cash flow growth trends

Over the last five reported fiscal years, free cash flow grew from −$1.3M to $6.5M, a net increase of $7.8M. Marimed's latest reported quarter, Q2 2026, generated $1.9M in free cash flow, an increase of $1.9M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Marimed filings at SEC.gov ↗